Browse all clinical evidence, news, and expert commentary
Dr Fatima Tahir explains the safeguards that underpin clinical trials in general practice, from ethical review and informed consent to Good Clinical Practice and ongoing safety monitoring.
The February 2026 NG28 update rewrote type 2 diabetes care for UK GPs. What changed, why it matters, and the four other NICE updates from the past year worth knowing.
Almost 90% of NHS patient contacts happen in primary care, yet most research still happens somewhere else. Dr Fatima Tahir on why that gap matters, and what practices stand to gain from closing it.
Dr Frederick Reynolds, a GP using ambient scribes day-to-day, has written the kind of thoughtful, first-hand review these tools deserve.
One in 10 patients surveyed by Kidney Care UK found out they had CKD by seeing it recorded in the NHS App. Almost 40% had no opportunity to discuss the diagnosis with a healthcare professional.
What the RCGP and Patients Association report means for GP workload, referrals, and NHS digital systems.
1 in 17 people will be affected by a rare disease in their lifetime. Most will wait years for a diagnosis. The default answer has always been that primary care needs more education — but is that actually true?
For 26 years, NICE has used the same yardstick to decide whether a new medicine is worth funding. From April 2026, that yardstick is changing for the first time, and prescribers will feel it.
Where is the money really flowing in healthcare?
